3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 6.14
-0.46 (-6.97%)
Oct 17, 2025, 4:08 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 1.51 billion as of October 17, 2025. Its market cap has increased by 155.13% in one year.
Market Cap
1.51B
Enterprise Value
1.10B
Revenue
491.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.14
Market Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 1.51B, a decrease of -78.55%. That is a compound annual growth rate of -41.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.51B | 99.63% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 270.59B |
| Hansoh Pharmaceutical Group Company | 216.37B |
| JD Health International | 205.69B |
| Innovent Biologics | 152.01B |
| WuXi Biologics | 148.98B |
| Sino Biopharmaceutical | 136.94B |
| Akeso | 117.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 110.39B |